BlackRock Fund Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Fund Advisors’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$189K	Buy	44,361 +1,484	+3%	+$7.18K	﹤0.01%	3437
2016 Q3	$214K	Sell	42,877 -59	-0.1%	-$249	﹤0.01%	3427
2016 Q2	$152K	Buy	42,936 +10,390	+32%	+$38.2K	﹤0.01%	3556
2016 Q1	$112K	Sell	32,546 -2,488	-7%	-$8.79K	﹤0.01%	3642
2015 Q4	$119K	Buy	35,034 +1,552	+5%	+$7.2K	﹤0.01%	3692
2015 Q3	$174K	Sell	33,482 -884	-3%	-$5.45K	﹤0.01%	3531
2015 Q2	$234K	Sell	34,366 -259,237	-88%	-$1.84M	﹤0.01%	3464
2015 Q1	$2.1M	Buy	293,603 +1,356	+0.5%	+$9.35K	﹤0.01%	3120
2014 Q4	$2.18M	Buy	292,247 +40,177	+16%	+$341K	﹤0.01%	3151
2014 Q3	$2.33M	Sell	252,070 -10,481	-4%	-$142K	﹤0.01%	3100
2014 Q2	$4.89M	Buy	262,551 +26,364	+11%	+$448K	﹤0.01%	2845
2014 Q1	$4.38M	Buy	+236,187	New	+$4.5M	﹤0.01%	2909

Other funds holding KIN

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

BlackRock Fund Advisors's KIN Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Kindred Biosciences, Inc. (KIN) stake by 3.5% in Q4 2016, buying an estimated $7.18K and bringing the position to 44,361 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #3437.

BlackRock Fund Advisors first reported a position in KIN in Q1 2014 and has held it in 12 quarters since. The position peaked at $4.89M in Q2 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Fund Advisors held 44,361 shares of Kindred Biosciences, Inc. worth $189K as of Q4 2016.
BlackRock Fund Advisors bought 1,484 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $7.18K.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3437 holding.
BlackRock Fund Advisors first reported a position in Kindred Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Fund Advisors's Kindred Biosciences, Inc. position peaked at $4.89M in Q2 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.